Oura Q4 sales rise 153% to $533M; to buy Counsel Health for $625M

Oura's growth is striking for a consumer hardware company, and the decision to spend $625 million on an AI doctor startup signals a strategic pivot from selling rings to selling health services. That matters for the broader wearables and digital-health space, where hardware margins are thin and recurring clinical engagement is the harder prize. The open question is whether a device maker can absorb a clinical AI business without regulatory and trust complications—and whether the acquisition price reflects durable revenue or an early-stage bet.